Table 1 Demographic details of the cohort.

From: The CloudUPDRS smartphone software in Parkinson’s study: cross-validation against blinded human raters

  

Range

 

Median

5th percentile

95th percentile

Age (years)

68

51.6

80

Disease duration (years)

5

1

17

Levodopa equivalent dose (mg/day)

452

100

1345.6

Montreal Cognitive Assessment (range = 0–30)

27

21.6

30

Beck Depression Inventory (range = 0–63)

9

1.6

25.8

PDQ-39 (range = 0–100)

32

6.6

77.9

Hoehn & Yahr (range 1–5)

2

2

2

MDS-UPDRS III (0–132)a

31.5

10.2

50.8

  1. Note that minimum Hoehn & Yahr stage was 1, the maximum was 4, but the frequency of these were low in this group.
  2. aThe total MDS-UPDRS III score provided is from the clinical assessor who performed the examination. Replacing individual subject subitem scores with the median of their counterpart blinded video ratings, changes the MDS-UPDRS III total population median to 26.5 (range 12–46).
Back to article page